Many of the decisions necessary at the end of life require disclosure that "this is the end of life." To withhold that knowledge until some arbitrary time before death robs patients of the ability to deal with financial issues, issues of independence, issues of unresolved personal or family ...
5.Device Therapy for Heart Failure and Angina Device therapy plays a critical role in the management ofadvanced heart failureand refractory angina, offering life-saving options for patients who do not respond adequately to pharmacological treatment. Implantable devices such ascardiac resynchronization thera...
Additionally, end-of-life care communication and prognosis of survival will be assessed with the physician primarily responsible for the management of the chronic organ failure. Finally, if patients decease during the study period, the baseline preferences with regard to life-sustaining treatments will...
Congestive Heart Failure (CHF) is a debilitating condition resulting from a structural or functional cardiac disorder that impedes the heart from filling with or ejecting a sufficient amount of blood to meet the needs of the body. Common symptoms of CHF include fatigue, decreased exercise tolerance...
451 Quality of life of caregivers is worse compared to patients with congestive heart failure 喜欢 0 阅读量: 5 作者: M LUTTIK 摘要: No objective, nor subjective amelioration was detectable in this group of patients with pigment epithelium tear due to anti VEGF treatment. 关键词: Blood ...
Lastly, in Stage D, all of the treatments for A, B and C apply, plus your doctor will determine if a heart transplant, ventricular assist devices, surgery or other therapies are a viable option. When people talk about congestive heart failure life expectancy, they are usually referring to ...
Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a... Sood, Manish M.,McCallum,etc.Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney ...
It was thought that although amiodarone therapy resulted in a substantial increase in left ventricular ejection fraction in patients with congestive heart failure, this was not associated with clinical benefit in the population as a whole. The substantial reduction in the combined end point of cardiac...
The safety and efficacy of long-term oral milrinone therapy were evaluated over a 2½ year period in 100 patients who had severe congestive heart failure despite conventional therapy. Long-term oral milrinone therapy (27 ± 8 mg/day initial dose) was well tolerated; drug-related side effects...
Heart failure (HF) is a major public health problem which is increasing in prevalence due to the aging of the population. Despite recent advances in the pharmacotherapy of HF, morbidity and mortality rates both remain high, owing in part to the presence of multiple medical, psychosocial, behavio...